Purchases and Sales Made in Q3 2024 in Edgewise Therapeutics, Inc. (EWTX)
This table provides information about the institutional ownership of Edgewise Therapeutics, Inc. (EWTX) during Q3 2024. The information is specifically focused on institutions that hold shares of Edgewise Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Vr Adviser, LLC
New York, NY |
SELL
|
- |
-818K- 45.0% |
$13M - $24.1M
|
1M
$13.7M
|
|
|
Nov 15, 2024
Q3 2024
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
SELL
|
- |
-898K- 24.07% |
$14.3M - $26.5M
|
2.83M
$38.9M
|
|
|
Nov 14, 2024
Q3 2024
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-1.09M- 38.04% |
$17.4M - $32.3M
|
1.78M
$24.5M
|
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.14M- 70.28% |
$18.1M - $33.6M
|
482K
$6.62M
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.81M- 77.09% |
$28.8M - $53.4M
|
538K
$7.39M
|